Drug:
Reaction: DERMATITIS ATOPIC
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491690 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 2 | 25491820 |
US |
2 | |
Dermatitis atopic, Photosensitivity reaction, Sunscreen sensitivity, |
||||
DUPILUMAB, |
||||
| 3 | 25491900 |
US |
1 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 4 | 25491916 |
US |
20 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 5 | 25495586 |
US |
70 | 2 |
Dermatitis atopic, Intentional dose omission, |
||||
DUPILUMAB, |
||||
| 6 | 25495587 |
US |
19 | 2 |
Dermatitis atopic, Skin discomfort, Sleep disorder due to a general medical condition, Pain, Rash, |
||||
DUPILUMAB, |
||||
| 7 | 25495595 |
US |
84 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 8 | 25495600 |
US |
28 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 9 | 25495617 |
US |
32 | 1 |
Dermatitis atopic, Intentional product misuse, |
||||
DUPILUMAB, |
||||
| 10 | 25495643 |
US |
15 | 1 |
Dermatitis atopic, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 11 | 25495660 |
US |
3 | 1 |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 12 | 25495672 |
US |
5 | 2 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 13 | 25495674 |
US |
1 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 14 | 25495679 |
US |
23 | 2 |
Dermatitis atopic, Product dose omission issue, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CYCLOSPORINE, |
||||
| 15 | 25495681 |
US |
7 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 16 | 25495682 |
US |
57 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 17 | 25495692 |
US |
2 | |
Dermatitis atopic, Pruritus, Erythema, Dermatitis, |
||||
DUPILUMAB, |
||||
| 18 | 25495710 |
US |
58 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 19 | 25495713 |
US |
46 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, CELECOXIB, CLONAZEPAM, FLUOCINOLONE ACETONIDE OIL, FLUOCINOLONE ACETONIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ESCITALOPRAM, LISINOPRIL, |
||||
| 20 | 25495719 |
US |
58 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 21 | 25495720 |
US |
25 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 22 | 25495729 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 23 | 25495749 |
US |
2 | 2 |
Dermatitis atopic, Temperature intolerance, Hyperhidrosis, |
||||
DUPILUMAB, |
||||
| 24 | 25495751 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 25 | 25495753 |
US |
36 | 2 |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, |
||||
| 26 | 25495762 |
US |
8 | 2 |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 27 | 25495793 |
US |
17 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 28 | 25495809 |
US |
43 | 1 |
Dermatitis atopic, Erythema, Swelling, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 29 | 25495814 |
US |
15 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 30 | 25495817 |
US |
48 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 31 | 25495828 |
US |
14 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 32 | 25495833 |
US |
56 | 2 |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 33 | 25495843 |
US |
44 | 2 |
Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 34 | 25495860 |
US |
38 | 2 |
Rash macular, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 35 | 25495893 |
US |
24 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 36 | 25495910 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 37 | 25495924 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 38 | 25495930 |
US |
42 | 1 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 39 | 25496068 |
US |
||
Dermatitis atopic, |
||||
RUXOLITINIB, |
||||
| 40 | 25496120 |
US |
70 | 2 |
Death, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 41 | 25496178 |
|||
Dermatitis atopic, Influenza, |
||||
RUXOLITINIB, |
||||
| 42 | 25496224 |
US |
4 | 2 |
Rash, Dermatitis atopic, Therapeutic response shortened, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 43 | 25496225 |
US |
6 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 44 | 25496272 |
US |
8 | 2 |
Dermatitis atopic, Rash, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 45 | 25490931 |
US |
38 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 46 | 25490936 |
US |
97 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 47 | 25490940 |
US |
59 | 2 |
Dermatitis atopic, Rash macular, Skin burning sensation, |
||||
DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, |
||||
| 48 | 25490942 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 49 | 25490945 |
US |
8 | 2 |
Dermatitis atopic, Dry skin, Pruritus, Skin fissures, |
||||
DUPILUMAB, |
||||
| 50 | 25490947 |
US |
52 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 51 | 25490950 |
US |
1 | |
Dermatitis contact, Back pain, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 52 | 25490966 |
US |
59 | 1 |
Dermatitis atopic, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 53 | 25491002 |
US |
1 | |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 54 | 25491010 |
US |
37 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 55 | 25491020 |
US |
38 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 56 | 25491070 |
US |
36 | 2 |
Feeling hot, Injection site swelling, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 57 | 25491090 |
US |
14 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, LANOLIN, |
||||
| 58 | 25491091 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 59 | 25491094 |
US |
23 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 60 | 25491101 |
US |
2 | |
Illness, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 61 | 25491110 |
US |
58 | 1 |
Dermatitis atopic, Injection site bruising, Injection site pain, |
||||
DUPILUMAB, |
||||
| 62 | 25491116 |
US |
9 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 63 | 25491118 |
US |
2 | |
Guttate psoriasis, Condition aggravated, Dermatitis atopic, Inappropriate schedule of product administration, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 64 | 25491121 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 65 | 25491122 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 66 | 25491123 |
US |
52 | 1 |
Dermatitis atopic, Skin irritation, |
||||
DUPILUMAB, |
||||
| 67 | 25491133 |
US |
1 | |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 68 | 25491150 |
US |
24 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 69 | 25491153 |
US |
1 | |
Hyperhidrosis, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 70 | 25491167 |
US |
1 | |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, FINASTERIDE, EMPAGLIFLOZIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 71 | 25491191 |
US |
26 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 72 | 25491211 |
US |
18 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 73 | 25491213 |
US |
24 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 74 | 25491219 |
US |
76 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 75 | 25491241 |
US |
14 | 1 |
Skin exfoliation, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 76 | 25491259 |
US |
21 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 77 | 25491300 |
US |
38 | 2 |
Dermatitis atopic, Scab, |
||||
DUPILUMAB, |
||||
| 78 | 25491304 |
US |
14 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 79 | 25491307 |
US |
15 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 80 | 25491332 |
US |
62 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 81 | 25491391 |
US |
4 | 1 |
Dermatitis atopic, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 82 | 25491392 |
US |
29 | 2 |
Dermatitis atopic, Rash erythematous, Eye pruritus, Vision blurred, |
||||
DUPILUMAB, |
||||
| 83 | 25491422 |
US |
2 | |
Dermatitis atopic, Rash, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 84 | 25491461 |
CA |
48 | 2 |
Surgery, Kidney infection, Dermatitis atopic, |
||||
UPADACITINIB, |
||||
| 85 | 25491539 |
US |
51 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 86 | 25489927 |
US |
56 | 1 |
Photosensitivity reaction, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 87 | 25489939 |
US |
2 | |
Sleep disorder due to a general medical condition, Dermatitis atopic, Asthma, Hypersensitivity, Impaired quality of life, |
||||
DUPILUMAB, AMLODIPINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VALSARTAN, VALSARTAN ORAL, GABAPENTIN, SEMAGLUTIDE, |
||||
| 88 | 25489993 |
US |
7 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 89 | 25490013 |
US |
1 | |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 90 | 25490025 |
US |
2 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 91 | 25490057 |
US |
22 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 92 | 25490065 |
US |
28 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 93 | 25490131 |
US |
10 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 94 | 25490154 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 95 | 25490172 |
US |
12 | 2 |
Dermatitis atopic, Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 96 | 25490220 |
US |
5 | 1 |
Dermatitis atopic, Therapeutic response decreased, Intentional product use issue, |
||||
DUPILUMAB, DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 97 | 25490237 |
US |
2 | |
Dermatitis atopic, Skin weeping, Infection, |
||||
DUPILUMAB, |
||||
| 98 | 25490288 |
US |
11 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 99 | 25490310 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 100 | 25490311 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PIMECROLIMUS, FEXOFENADINE HYDROCHLORIDE, ALBUTEROL SULFATE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, FISH OIL, MAGNESIUM OXIDE, FENOFIBRATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29